Anakinra biosimilar - Sunshine Guojian Pharmaceutical

Drug Profile

Anakinra biosimilar - Sunshine Guojian Pharmaceutical

Alternative Names: Interleukin-1 receptor antagonist - Sunshine Guojian Pharmaceutical

Latest Information Update: 04 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shanghai CP Guojian Pharmaceutical
  • Class Anti-inflammatories; Recombinant proteins
  • Mechanism of Action Interleukin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Dec 2011 Discontinued - Phase-III for Rheumatoid arthritis in China (SC)
  • 01 Jan 2008 Phase-III clinical trials in Rheumatoid arthritis in China (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top